Legend Biotech Corporation
LEGNDrugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
6dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
LEGN Earnings Report
EPS Est: $0.12 | FQ end 2026-06 | Call: 2026-08-11 15:00:00
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Legend Biotech Corporation's next FDA catalyst?→
Legend Biotech Corporation's (LEGN) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track LEGN biotech catalysts?→
Add LEGN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Legend Biotech Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.